spacer
home > pmps > autumn 2008 > a revolution in aseptic filling
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Revolution in Aseptic Filling

The aseptic filling of injectable drugs has always been a challenge for the pharmaceutical industry. Contamination accidents, despite being rare, are still recorded among the 20 billion injections and infusions made every year in the world.

In a recent market study, six per cent of hospital professionals in Europe and the US reported that they have already faced at least one case of contaminated vials. In recent years, the authorities have taken a radical turn to strongly support the most advanced aseptic filling technologies, such as the use of isolators, whereas the use of classical processes in an Iso 5/Grade A cleanroom are more and more questioned, as the risks caused by proximity of operators to the open containers becomes evident...


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Benoоt Verjans has a PhD degree in Biochemistry and a MBA from the University of Brussels. He has developed a post-doctoral programme at the University of Cambridge (UK). He worked at UCB Pharma in International Marketing, at McKinsey and Co as a consultant, in the pharma sector (marketing, supply chain and licensing projects), and as CEO of 4AZA Bioscience, a start-up from the University of Leuven developing new immuno-modulating drugs. He is currently Commercial Director of Aseptic Technologies, responsible for developing the sales of closed vial technology worldwide. He is on the Editorial Board of Pharmaceutical Technology Europe and a member of ISPE.
spacer
Benoоt Verjans
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera acquires Insight Product Development to strengthen its capabilities

“Every day at Nemera, we work to improve the lives of millions of patients worldwide by designing, developing and manufacturing innovative drug delivery devices. Our vision as a team is to become the most patient-centric drug delivery device company in the industry. We partner closely with our customers to deliver innovative and high quality devices, to ensure that patients will receive the best product and service possible” Marc Hämel, CEO
More info >>

White Papers

Assessing the Integrity of Pharmaceutical Packaging Using the Sepha Blisterscan and Conventional Blue Dye Leak Testing Methods

Sepha Limited

A new whitepaper by a leading packaging expert from the University of Ulster, Dr Dorian Dixon, into the integrity of pharmaceutical packaging has established that existing methods for testing the seal integrity of blister packs are not as accurate as newer, technology based test equipment.
More info >>

 
Industry Events

INTERPHEX 2020

28-30 April 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement